SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: jaybe who wrote (4351)8/3/2016 9:58:22 PM
From: jesspro  Read Replies (3) | Respond to of 4474
 
Jaybe, supposing many new virgin patients are prescribed Brigatinib (off label) by conscientious oncologists, Granting that the results of these off label treatments are parallel to their clinical trials(on par or better than Alec), is that not enough as a bargaining tool for the company to appeal for a 1st line case to the FDA?